Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| index_cardiovascular [2024/11/05 01:46] – removed - external edit (Unknown date) 127.0.0.1 | index_cardiovascular [2024/11/23 17:26] (current) – jkohts | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Cardiovascular drugs ====== | ||
| + | |||
| + | <WRAP column 30%> | ||
| + | |||
| + | * Antidysrhythmics | ||
| + | * Class I | ||
| + | * Quinidine - 1a | ||
| + | * Procainamide - 1a | ||
| + | * Lidocaine - 1b | ||
| + | * Propafenone - 1c | ||
| + | * Class II | ||
| + | * Propranolol | ||
| + | * Atenolol | ||
| + | * Metoprolol | ||
| + | * Class III | ||
| + | * Amiodarone | ||
| + | * Dronedarone | ||
| + | * Dofetilide | ||
| + | * Ibutilide | ||
| + | * Sotalol | ||
| + | * Class IV | ||
| + | * Verapamil | ||
| + | * Diltiazem | ||
| + | * Misc | ||
| + | * Adenosine | ||
| + | * Atropine | ||
| + | * Ivabradine | ||
| + | |||
| + | </ | ||
| + | |||
| + | <WRAP column 30%> | ||
| + | |||
| + | * Heart failure treatment | ||
| + | * [[beta_blocker_toxicity|Beta blockers]] | ||
| + | * ACE-i | ||
| + | * ARB | ||
| + | * MRA | ||
| + | * ARNI | ||
| + | * Sacubitril/ | ||
| + | * SGLT2 inhihbitors | ||
| + | * Dapagliflozin… | ||
| + | * Diuretics | ||
| + | * Hypolipidemics | ||
| + | * Statins | ||
| + | * PCSK9 inhibitors | ||
| + | * Bile acid-binding resins | ||
| + | * Fibric acid derivatives | ||
| + | * Cholesterol absorption inhibitors | ||
| + | * Nicotinic acid | ||
| + | * Omega-3 fatty acid | ||
| + | * SiRNA | ||
| + | |||
| + | </ | ||
| + | |||
| + | <WRAP column 30%> | ||
| + | |||
| + | * Antihypertensives | ||
| + | * ACE-i | ||
| + | * ARB | ||
| + | * Arterial vasodilators | ||
| + | * Hydralazine | ||
| + | * Minoxidil | ||
| + | * Alpha blockers | ||
| + | * Prazosin | ||
| + | * Doxazosin | ||
| + | * Terazosin | ||
| + | * Beta blockers | ||
| + | * Propranolol | ||
| + | * Metoprolol | ||
| + | * Nebivolol | ||
| + | * Calcium channel blockers | ||
| + | * Dihydropyridines | ||
| + | * Diltiazem | ||
| + | * Verapamil | ||
| + | * Other | ||
| + | * Methyldopa | ||
| + | * Clonidine | ||
| + | * Aliskiren | ||
| + | * | ||
| + | |||
| + | </ | ||
| + | |||